Investing Profile

Scott Gottlieb

VCInvestor

Special Partner at New Enterprise Associates (NEA)

nea.com/team/scott-gottlieb-m...Washington, District of Columbia

‌

Your Intro Paths to Scott Gottlieb

‌

Networks Scott is a member of

New Enterprise Associates Network

16 CONNECTIONS

Wesleyan University Network

14 CONNECTIONS

Find Scott Gottlieb on

Current Investing Position

New Enterprise Associates (NEA) Partner

Investment Range

$2.0M - $50.0M

Sweet Spot

$25.0M

Investments On Record

Current Fund Size

$6.2B

Scott Gottlieb is on these Sector & Stage Rankings

Medical Devices (Seed)Pharmaceuticals (Seed)BioTech (Series B)Medical Devices (Series B)BioTech (Seed)Pharmaceuticals (Series B)Health & Hospital Services (Series B)Washington, D.C.Health IT (Seed)Health IT (Series B)Health & Hospital Services (Seed)

Scott Gottlieb's Investments On Record (3)

Company	StageDateRound Size	Total Raised
Xaira Therapeutics	Series AApr 2024$1B	$1B
Co-investors: Robert Nelsen (ARCH Venture Partners), Vikram Bajaj (Foresite Capital)
Comanche Biopharma	Series BJan 2024$75M	$75M
Co-investors: David Grayzel (Atlas Venture)
Resilience	Series BNov 2020$750M	$830M
Co-investors: Drew Oetting (8VC), Josh Wolfe (Lux Capital), Robin Godenrath (Picus Capital), Xavier Niel (Kima Ventures), Eduardo Ronzano (#SecretFund), Robert Nelsen (ARCH Venture Partners), Jean Charles Samuelian, Roxanne Varza

Scott Gottlieb's Experience

Member of the Board of Directors Pfizer2019 - Present

Elected Member National Academy of Medicine2018 - Present

Partner New Enterprise Associates2007 - Present

Senior Fellow American Enterprise Institute2003 - Present

Commissioner FDA2017 - 2019

Member of the Board of Directors Gradalis, Inc.2015 - 2017

Independent Member of the Board of Directors Daiichi Sankyo, Inc.2015 - 2017

Member Federal Health IT Policy Committee U.S. Department of Health and Human Services (HHS)2013 - 2017

Independent Member of the Board of Directors American Pathology Partners2012 - 2017

Member of the Policy Board Society of Hospital Medicine2011 - 2017

Clinical Assistant Professor NYU Langone Health2011 - 2017

Member of the Product Investment Board GlaxoSmithKline2010 - 2017

Member of the Board of Directors MedAvante2007 - 2017

Member of the Board of Directors Tolero Pharmaceuticals, Inc.2015 - 2016

Member of the Policy Board The Leukemia & Lymphoma Society2012 - 2014

Member of the Board of Directors Aptiv Solutions2012 - 2014

Independent Member of the Board of Directors Bravo Health2009 - 2011

Independent Member of the Board of Directors Molecular Insight Pharmaceuticals2007 - 2010

Deputy Commissioner for Medical and Scientific Affairs FDA2005 - 2007

Senior Adviser to the Administrator Centers for Medicare & Medicaid Services2004 - 2004

Senior Adviser to the Commissioner and Director of Medical Policy Development FDA2003 - 2004

Medical Staff Writer British Medical Journal1998 - 2003

Investment Banking Analyst Alex Brown & Sons1994 - 1995

Scott Gottlieb's Education

Mount Sinai School of Medicine of New York University Resident Internal Medicine Residency Program

Mount Sinai School of Medicine of New York University Doctor of Medicine (MD) Medicine

Wesleyan University BA Economics